Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Study of Macular Function During Anti-VEGF Treatment
Authors not listed
Royal Liverpool University Hospital · 2009
Abstract
The purpose of this study is to determine the changes in macular function during anti-VEGF treatment for neovascular age-related macular degeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2009). Study of Macular Function During Anti-VEGF Treatment. <em>Royal Liverpool University Hospital</em>. https://clinicaltrials.gov/study/NCT01023971
Vancouver
Anonymous. Study of Macular Function During Anti-VEGF Treatment. Royal Liverpool University Hospital. 2009.
BibTeX
@misc{anon2009Studyo,
title = {Study of Macular Function During Anti-VEGF Treatment},
author = {Anonymous},
journal = {Royal Liverpool University Hospital},
year = {2009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2006
Citation only
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
American Journal of Ophthalmology 2007
Citation only
Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration
GlaxoSmithKline 2010
Open access · US-GOV
MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops Versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration
American Journal of Ophthalmology 1995
Citation only